MARAVIROC Side Effects

7012803-8 | Renal Failure Acute
on Sep 17, 2010 Male patient from AUSTRALIA , weighting 230.4 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Maraviroc dosage: 300mg Twice Per Day. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), BISPHOSPHONATES (NOS) (View Bisphosphonates (nos) Review and Bisphosphonates (nos) Label ), METFORMIN (View Metformin Review and Metformin Label ), KAPANOL (View Kapanol Review and Kapanol Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), BACTRIM (View Bactrim Review and Bactrim Label ), KARVEZIDE (View Karvezide Review and Karvezide Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized and became disabled.

6978707-1 | Completed Suicide
Patient was taking Maraviroc (View Usage). Patient had the following side effects: completed suicide on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , 40 years of age, weighting 267.9 lb, was diagnosed with hiv infection (What is hiv infection?) and. Maraviroc dosage: 150mg Twice Per Day. During the same period patient was treated with PROPOXYPHENE HCL AND ACETAMINOPHEN (View Propoxyphene Hcl And Acetaminophen Review and Propoxyphene Hcl And Acetaminophen Label ), EPZICOM (View Epzicom Review and Epzicom Label ), TRUVADA (View Truvada Review and Truvada Label ), FOSAMPRENAVIR (View Fosamprenavir Review and Fosamprenavir Label ), NORVIR (View Norvir Review and Norvir Label ), VIREAD (View Viread Review and Viread Label ), LASIX (View Lasix Review and Lasix Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ).

6970862-2 | Myocardial Infarction
Adverse event was reported on Sep 02, 2010 by a Female patient taking Maraviroc (View Usage) (Dosage: 300mg Twice Per Day) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 47 years of age, weighting 127.2 lb, After Maraviroc was administered, patient had the following side effects: myocardial infarction. During the same period patient was treated with VIREAD (300mg Two Times Per Week) (View Viread Review and Viread Label ), PREZISTA (400mg Twice Per Day) (View Prezista Review and Prezista Label ), NORVIR (100mg Per Day) (View Norvir Review and Norvir Label ).

6965464-8 | Non-hodgkin's Lymphoma
on Aug 25, 2010 Male patient from ITALY , weighting 114.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: non-hodgkin's lymphoma. Maraviroc dosage: 150mg Twice Per Day. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.


6963432-3 | Completed Suicide
on Aug 23, 2010 Female patient from UNITED STATES , 40 years of age, weighting 267.9 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient had the following side effects: completed suicide. Maraviroc dosage: 150mg Twice Per Day. During the same period patient was treated with PROPOXYPHENE HCL AND ACETAMINOPHEN (View Propoxyphene Hcl And Acetaminophen Review and Propoxyphene Hcl And Acetaminophen Label ), EPZICOM (View Epzicom Review and Epzicom Label ), TRUVADA (View Truvada Review and Truvada Label ), FOSAMPRENAVIR (View Fosamprenavir Review and Fosamprenavir Label ), NORVIR (View Norvir Review and Norvir Label ), VIREAD (View Viread Review and Viread Label ), LASIX (View Lasix Review and Lasix Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ).

6961349-1 | Large Intestine Perforation
Patient was taking Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: large intestine perforation on Aug 24, 2010 from UNITED STATES Additional patient health information: Male patient , 51 years of age, weighting 137.3 lb, was diagnosed with hiv infection (What is hiv infection?), herpes virus infection, wheezing and. Maraviroc dosage: 150mg Per Day. During the same period patient was treated with DARUNAVIR (800mg Per Day) (View Darunavir Review and Darunavir Label ), RITONAVIR (100mg Per Day) (View Ritonavir Review and Ritonavir Label ), ASTEPRO (View Astepro Review and Astepro Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), PROVENTIL (View Proventil Review and Proventil Label ), LEVITRA (View Levitra Review and Levitra Label ), OPTIVAR (View Optivar Review and Optivar Label ). Patient was hospitalized.

6956408-3 | Bladder Neoplasm
Adverse event was reported on Aug 19, 2010 by a Male patient taking Maraviroc (View Usage) (Dosage: 300mg Twice Per Day) was diagnosed with hiv infection (What is hiv infection?), prophylaxis and. Location: SPAIN , weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: bladder neoplasm. During the same period patient was treated with DARUNAVIR ETHANOLATE (800mg Per Day) (View Darunavir Ethanolate Review and Darunavir Ethanolate Label ), RITONAVIR (100mg Per Day) (View Ritonavir Review and Ritonavir Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), BEMIPARIN (View Bemiparin Review and Bemiparin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6921295-6 | Acute Myocardial Infarction
on Aug 03, 2010 Male patient from ARGENTINA , weighting 156.5 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient had the following side effects: acute myocardial infarction. Maraviroc dosage: 300mg Twice Per Day. During the same period patient was treated with COMBIVIR (450mg Twice Per Day) (View Combivir Review and Combivir Label ). Patient was hospitalized.

6919450-4 | Pruritus
on Aug 04, 2010 Male patient from SOUTH AFRICA , weighting 120.6 lb, was diagnosed with hiv infection (What is hiv infection?), tuberculosis (What is tuberculosis?) and was treated with Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: pruritus. Maraviroc dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), STOCRIN (View Stocrin Review and Stocrin Label ), RIFAMPICIN (600mg Per Day) (View Rifampicin Review and Rifampicin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PROBON (View Probon Review and Probon Label ), VIT B (View Vit B Review and Vit B Label ), IMODIUM (View Imodium Review and Imodium Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ).

6907169-5 | Lymphoma, Psoriasis, Septic Shock
Patient was taking Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: lymphoma (What is lymphoma?), psoriasis, septic shock on Jan 09, 2010 from BELGIUM Additional patient health information: Male patient , weighting 123.9 lb, . Maraviroc dosage: 300 Mg, 2x/day. During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), COMBIVIR (View Combivir Review and Combivir Label ), TIPRANAVIR (View Tipranavir Review and Tipranavir Label ), BACTRIM (View Bactrim Review and Bactrim Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ). Patient was hospitalized.

6907167-1 | Abdominal Pain, Decreased Appetite, Nausea
Adverse event was reported on Apr 13, 2010 by a Female patient taking Maraviroc (View Usage) (Dosage: 150 Mg, 2x/day) was diagnosed with hiv infection (What is hiv infection?) and. Location: BRAZIL , weighting 146.6 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), decreased appetite, nausea (What is nausea?). During the same period patient was treated with DARUNAVIR (300 Mg, 2x/day) (View Darunavir Review and Darunavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6907158-0 | Polyarthritis
on Dec 21, 2009 Male patient from AUSTRALIA , weighting 218.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: polyarthritis. Maraviroc dosage: 600 Mg, 2x/day. During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), ABACAVIR SULFATE/LAMIVUDINE (600/300 Mg) (View Abacavir Sulfate/lamivudine Review and Abacavir Sulfate/lamivudine Label ), LYRICA (View Lyrica Review and Lyrica Label ), SOMAC (View Somac Review and Somac Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

6907157-9 | Abdominal Pain, Amnesia, Diarrhoea, Flatulence, Gait Disturbance, Pancytopenia, Pyrexia, Sepsis
on Mar 17, 2010 Male patient from BRAZIL , weighting 123.5 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), amnesia, diarrhoea, flatulence, gait disturbance, pancytopenia, pyrexia, sepsis (What is sepsis?). Maraviroc dosage: 150 Mg, 2x/day. During the same period patient was treated with ZIDOVUDINE (Everyday) (View Zidovudine Review and Zidovudine Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), DAPSONE (View Dapsone Review and Dapsone Label ), PYRIMETHAMINE (View Pyrimethamine Review and Pyrimethamine Label ). Patient was hospitalized.

6907141-5 | Squamous Cell Carcinoma
Patient was taking Maraviroc (View Usage). Patient had the following side effects: squamous cell carcinoma on Feb 19, 2009 from AUSTRALIA Additional patient health information: Male patient , weighting 158.7 lb, was diagnosed with hiv infection (What is hiv infection?) and. Maraviroc dosage: 150 Mg, 2x/day. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VALACYCLOVIR (View Valacyclovir Review and Valacyclovir Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).

6907109-9 | Squamous Cell Carcinoma
Adverse event was reported on May 27, 2009 by a Male patient taking Maraviroc (View Usage) (Dosage: 600 Mg, 2x/day) was diagnosed with hiv infection (What is hiv infection?) and. Location: ITALY , weighting 130.1 lb, After Maraviroc was administered, patient had the following side effects: squamous cell carcinoma. During the same period patient was treated with FOSAMPRENAVIR (View Fosamprenavir Review and Fosamprenavir Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), ABACAVIR (View Abacavir Review and Abacavir Label ).

6907102-6 | Breast Calcifications, Breast Cancer
on Mar 12, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: breast calcifications, breast cancer (What is breast cancer?). Maraviroc dosage: 300 Mg, 2x/day. During the same period patient was treated with COMBIVIR (300/150 Mg) (View Combivir Review and Combivir Label ), TRUVADA (200mg/300mg,daily) (View Truvada Review and Truvada Label ). Patient was hospitalized.

6907085-9 | Rectal Cancer
on Sep 23, 2008 Male patient from UNITED STATES , weighting 183.9 lb, was diagnosed with procedural pain, anaemia and was treated with Maraviroc (View Usage). Patient had the following side effects: rectal cancer. Maraviroc dosage: . During the same period patient was treated with OXYCODONE (View Oxycodone Review and Oxycodone Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

6907084-7 | Testicular Neoplasm, Testicular Swelling
Patient was taking Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: testicular neoplasm, testicular swelling on Oct 06, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 150.6 lb, was diagnosed with hiv infection (What is hiv infection?) and. Maraviroc dosage: . During the same period patient was treated with ZITHROMAX (View Zithromax Review and Zithromax Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), KALETRA (View Kaletra Review and Kaletra Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), REYATAZ (View Reyataz Review and Reyataz Label ), ISENTRESS (View Isentress Review and Isentress Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

6907083-5 | Hodgkin's Disease
Adverse event was reported on Jul 16, 2008 by a Male patient taking Maraviroc (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , weighting 109.6 lb, Patient experienced the following unwanted or unexpected effects: hodgkin's disease (What is hodgkin's disease?). During the same period patient was treated with TIPRANAVIR (View Tipranavir Review and Tipranavir Label ), ABACAVIR SULFATE/LAMIVUDINE (View Abacavir Sulfate/lamivudine Review and Abacavir Sulfate/lamivudine Label ), NORVIR (View Norvir Review and Norvir Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), VIDEX (View Videx Review and Videx Label ).

6907077-X | Hepatic Failure
on Oct 23, 2008 Male patient from UNITED STATES , weighting 185.0 lb, was diagnosed with hiv test positive (What is hiv test positive?), anxiety (What is anxiety?), ascites and was treated with Maraviroc (View Usage). Patient had the following side effects: hepatic failure. Maraviroc dosage: . During the same period patient was treated with LAMIVUDINE + ZIDOVUDINE (300/150mg) (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6907075-6 | Vitreous Floaters
on Nov 10, 2008 Male patient from ITALY , weighting 154.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: vitreous floaters. Maraviroc dosage: 150 Mg, 2x/day. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), PREZISTA (View Prezista Review and Prezista Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SEACOR (View Seacor Review and Seacor Label ). Patient was hospitalized.

6907067-7 | Rectal Cancer
Patient was taking Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: rectal cancer on Jul 07, 2008 from UNITED KINGDOM Additional patient health information: Male patient , weighting 153.9 lb, was diagnosed with hiv infection (What is hiv infection?) and. Maraviroc dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), DAPSONE (View Dapsone Review and Dapsone Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ).

6907059-8 | Anal Cancer
Adverse event was reported on Jun 17, 2008 by a Male patient taking Maraviroc (View Usage) (Dosage: Frequency: Bid; Interval: Daily) was diagnosed with hiv test positive (What is hiv test positive?) and. Location: UNITED STATES , weighting 168.0 lb, Patient had the following side effects: anal cancer (What is anal cancer?). During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), VALACYCLOVIR (View Valacyclovir Review and Valacyclovir Label ), PREVACID (View Prevacid Review and Prevacid Label ), SOMATROPIN (View Somatropin Review and Somatropin Label ).

6907055-0 | Coronary Artery Disease
on Aug 13, 2008 Male patient from CANADA , weighting 213.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: coronary artery disease (What is coronary artery disease?). Maraviroc dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), BEZAFIBRATE (View Bezafibrate Review and Bezafibrate Label ), SELENIUM (View Selenium Review and Selenium Label ), MITOMYCIN (View Mitomycin Review and Mitomycin Label ). Patient was hospitalized.

6907054-9 | Bacteraemia, Diarrhoea, Hypokalaemia
on Jul 22, 2008 Male patient from FRANCE , weighting 167.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, diarrhoea, hypokalaemia. Maraviroc dosage: . During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), FOSCARNET (View Foscarnet Review and Foscarnet Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), ATOVAQUONE (View Atovaquone Review and Atovaquone Label ). Patient was hospitalized.

6907048-3 | Oesophageal Carcinoma, Oesophageal Stenosis
Patient was taking Maraviroc (View Usage). Patient had the following side effects: oesophageal carcinoma, oesophageal stenosis on Nov 07, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 152.1 lb, was diagnosed with hiv infection (What is hiv infection?), anxiety (What is anxiety?), vitamin supplementation, seasonal allergy, nasal congestion and. Maraviroc dosage: . During the same period patient was treated with ANDROGEL (View Androgel Review and Androgel Label ), TRUVADA (View Truvada Review and Truvada Label ), TRIAMCINOLONE (0.05%) (View Triamcinolone Review and Triamcinolone Label ), VALIUM (5-10 Mg) (View Valium Review and Valium Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), NASAREL (2 Sprays Bid) (View Nasarel Review and Nasarel Label ), KALETRA (1066/266 Mg) (View Kaletra Review and Kaletra Label ). Patient was hospitalized.

6907044-6 | Myocardial Infarction
Adverse event was reported on Nov 24, 2008 by a Male patient taking Maraviroc (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , weighting 199.1 lb, After Maraviroc was administered, patient had the following side effects: myocardial infarction. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), VICODIN (View Vicodin Review and Vicodin Label ), PHENYTOIN SODIUM (View Phenytoin Sodium Review and Phenytoin Sodium Label ), ANDROGEL (View Androgel Review and Androgel Label ), FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), LOMOTIL (View Lomotil Review and Lomotil Label ), VIRAMUNE (View Viramune Review and Viramune Label ), EPZICOM (View Epzicom Review and Epzicom Label ). Patient was hospitalized.

6907035-5 | Pancreatitis
on Jun 13, 2008 Male patient from ITALY , weighting 158.7 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Maraviroc dosage: . During the same period patient was treated with RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ETRAVIRINE (View Etravirine Review and Etravirine Label ), BACTRIM (View Bactrim Review and Bactrim Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

6907024-0 | Lipodystrophy Acquired
on Jul 09, 2008 Female patient from UNITED STATES , 21 years of age, weighting 140.9 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient had the following side effects: lipodystrophy acquired. Maraviroc dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), PREZISTA (View Prezista Review and Prezista Label ).

6907016-1 | Hepatic Failure
Patient was taking Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: hepatic failure on Jun 02, 2008 from SPAIN Additional patient health information: Male patient , weighting 136.7 lb, was diagnosed with hiv infection (What is hiv infection?) and. Maraviroc dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), DARUNAVIR (View Darunavir Review and Darunavir Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), MST (View Mst Review and Mst Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ).

6907011-2 | Paraganglion Neoplasm
Adverse event was reported on Jun 04, 2008 by a Male patient taking Maraviroc (View Usage) (Dosage: ) was diagnosed with hiv test positive (What is hiv test positive?) and. Location: UNITED STATES , weighting 192.9 lb, Patient experienced the following unwanted or unexpected effects: paraganglion neoplasm. Patient was hospitalized.

6907009-4 | Acute Myocardial Infarction
on Jun 12, 2008 Male patient from UNITED STATES , weighting 170.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient had the following side effects: acute myocardial infarction. Maraviroc dosage: . During the same period patient was treated with VIDEX (View Videx Review and Videx Label ), VIREAD (View Viread Review and Viread Label ), KALETRA (Ud: 400/100mg; Tdd: 800/200mg) (View Kaletra Review and Kaletra Label ), PERCOCET (View Percocet Review and Percocet Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), VITAMIN B (View Vitamin B Review and Vitamin B Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6906997-X | Anal Cancer Stage Iii
on May 12, 2008 Male patient from ITALY , weighting 191.8 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: anal cancer stage iii. Maraviroc dosage: Bid Every Day. During the same period patient was treated with ETRAVIRINE (View Etravirine Review and Etravirine Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ). Patient was hospitalized.

6906983-X | Squamous Cell Carcinoma
Patient was taking Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: squamous cell carcinoma on Jun 04, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 184.1 lb, was diagnosed with hiv test positive (What is hiv test positive?) and. Maraviroc dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRICOR (View Tricor Review and Tricor Label ), DAPSONE (View Dapsone Review and Dapsone Label ), INVIRASE (View Invirase Review and Invirase Label ), FOSAMPRENAVIR (View Fosamprenavir Review and Fosamprenavir Label ), VIDEX (View Videx Review and Videx Label ).

6867191-4 | Large Intestine Perforation
Adverse event was reported on Jul 15, 2010 by a Male patient taking Maraviroc (View Usage) (Dosage: 150mg Per Day) was diagnosed with hiv infection (What is hiv infection?), herpes virus infection, wheezing and. Location: UNITED STATES , 51 years of age, weighting 137.3 lb, Patient had the following side effects: large intestine perforation. During the same period patient was treated with DARUNAVIR (800mg Per Day) (View Darunavir Review and Darunavir Label ), RITONAVIR (100mg Per Day) (View Ritonavir Review and Ritonavir Label ), ASTEPRO (View Astepro Review and Astepro Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), PROVENTIL (View Proventil Review and Proventil Label ), LEVITRA (View Levitra Review and Levitra Label ), OPTIVAR (View Optivar Review and Optivar Label ). Patient was hospitalized.

6857134-1 | Cytolytic Hepatitis
on Jul 06, 2010 Female patient from FRANCE , weighting 110.2 lb, was diagnosed with hiv infection (What is hiv infection?), tuberculosis (What is tuberculosis?) and was treated with Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: cytolytic hepatitis. Maraviroc dosage: 600mg Twice Per Day. During the same period patient was treated with RIFAMATE (1tab Twice Per Day) (View Rifamate Review and Rifamate Label ), PYRAZINAMIDE (500mg Three Times Per Day) (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL HYDROCHLORIDE (400mg Three Times Per Day) (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), ATRIPLA (View Atripla Review and Atripla Label ). Patient was hospitalized.

6848187-5 | Acquired Immunodeficiency Syndrome, Atrial Fibrillation, Chest Pain
on Jul 12, 2010 Male patient from UNITED STATES , 64 years of age, weighting 134.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: acquired immunodeficiency syndrome, atrial fibrillation (What is atrial fibrillation?), chest pain (What is chest pain?). Maraviroc dosage: 150mg Twice Per Day. Patient was hospitalized.

6836037-2 | Bladder Neoplasm, Transitional Cell Carcinoma
Patient was taking Maraviroc (View Usage). Patient had the following side effects: bladder neoplasm, transitional cell carcinoma on Jul 09, 2010 from SPAIN Additional patient health information: Male patient , weighting 136.7 lb, was diagnosed with hiv infection (What is hiv infection?) and. Maraviroc dosage: 300mg Twice Per Day. During the same period patient was treated with DARUNAVIR (800mg Per Day) (View Darunavir Review and Darunavir Label ), RITONAVIR (100mg Per Day) (View Ritonavir Review and Ritonavir Label ).

6817527-5 | Myocardial Ischaemia
Adverse event was reported on Jul 02, 2010 by a Male patient taking Maraviroc (View Usage) (Dosage: 150mg Twice Per Day) was diagnosed with hiv infection (What is hiv infection?), irritable bowel syndrome (What is irritable bowel syndrome?), asthma (What is asthma?) and. Location: UNITED KINGDOM , 49 years of age, weighting 143.3 lb, After Maraviroc was administered, patient had the following side effects: myocardial ischaemia. During the same period patient was treated with ASPIRIN (75mg Per Day) (View Aspirin Review and Aspirin Label ), DARUNAVIR (600mg Twice Per Day) (View Darunavir Review and Darunavir Label ), DILTIAZEM (300mg Per Day) (View Diltiazem Review and Diltiazem Label ), ISOSORBIDE MONONITRATE (40mg Twice Per Day) (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), MEBEVERINE (135mg Three Times Per Day) (View Mebeverine Review and Mebeverine Label ), NICORANDIL (20mg Twice Per Day) (View Nicorandil Review and Nicorandil Label ), OMEPRAZOLE (20mg Per Day) (View Omeprazole Review and Omeprazole Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ). Patient was hospitalized and became disabled.

6810030-8 | Bladder Neoplasm
on Jun 23, 2010 Male patient from SPAIN , weighting 136.7 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: bladder neoplasm. Maraviroc dosage: 300mg Twice Per Day. During the same period patient was treated with DARUNAVIR (800mg Per Day) (View Darunavir Review and Darunavir Label ), RITONAVIR (100mg Per Day) (View Ritonavir Review and Ritonavir Label ).

6795922-0 | Abdominal Pain, Decreased Appetite, Nausea
on Jun 22, 2010 Female patient from BRAZIL , weighting 146.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), decreased appetite, nausea (What is nausea?). Maraviroc dosage: 150mg Twice Per Day. During the same period patient was treated with DARUNAVIR (600mg Twice Per Day) (View Darunavir Review and Darunavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE HIV (View Lamivudine-hiv Review and Lamivudine-hiv Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6790898-4 | Abdominal Pain, Rectal Haemorrhage
Patient was taking Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), rectal haemorrhage on Jun 13, 2010 from UNITED STATES Additional patient health information: Male patient , 51 years of age, weighting 137.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Maraviroc dosage: 150mg Per Day. Patient was hospitalized.

6779632-1 | Abdominal Pain, Decreased Appetite, Nausea
Adverse event was reported on Jun 16, 2010 by a Female patient taking Maraviroc (View Usage) (Dosage: 150mg Twice Per Day) was diagnosed with hiv infection (What is hiv infection?) and. Location: BRAZIL , weighting 146.6 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), decreased appetite, nausea (What is nausea?). During the same period patient was treated with DARUNAVIR (300mg Twice Per Day) (View Darunavir Review and Darunavir Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), LAMIVUDINE HIV (View Lamivudine-hiv Review and Lamivudine-hiv Label ), ENFUVIRTIDE (View Enfuvirtide Review and Enfuvirtide Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6768045-4 | Vulvovaginal Mycotic Infection
on Jun 09, 2010 Female patient from FRANCE , weighting 180.8 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). Patient had the following side effects: vulvovaginal mycotic infection. Maraviroc dosage: . During the same period patient was treated with ETRAVIRINE (400mg Twice Per Day) (View Etravirine Review and Etravirine Label ), TIPRANAVIR (500mg Twice Per Day) (View Tipranavir Review and Tipranavir Label ), RITONAVIR (200mg Twice Per Day) (View Ritonavir Review and Ritonavir Label ), TRUVADA (1tab Per Day) (View Truvada Review and Truvada Label ). Patient was hospitalized.

6761071-0 | Vulvovaginal Mycotic Infection
on May 31, 2010 Female patient from FRANCE , weighting 180.8 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: vulvovaginal mycotic infection. Maraviroc dosage: . During the same period patient was treated with ETRAVIRINE (400mg Twice Per Day) (View Etravirine Review and Etravirine Label ), TIPRANAVIR (500mg Twice Per Day) (View Tipranavir Review and Tipranavir Label ), RITONAVIR (200mg Twice Per Day) (View Ritonavir Review and Ritonavir Label ), TRUVADA (1tab Per Day) (View Truvada Review and Truvada Label ). Patient was hospitalized.

6754019-6 |
Patient was taking Maraviroc (View Usage). on May 19, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Maraviroc dosage: 150mg Twice Per Day. Patient was hospitalized.

6725549-8 | Non-hodgkin's Lymphoma
Adverse event was reported on May 12, 2010 by a Male patient taking Maraviroc (View Usage) (Dosage: 150 Mg, 2x/day) . Location: FRANCE , 46 years of age, weighting 176.4 lb, Patient had the following side effects: non-hodgkin's lymphoma. Patient was hospitalized.

6724524-7 | Arteriosclerosis, Coronary Artery Occlusion, Myocardial Infarction
on May 07, 2010 Male patient from CANADA , 60 years of age, weighting 177.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Maraviroc (View Usage). After Maraviroc was administered, patient had the following side effects: arteriosclerosis, coronary artery occlusion, myocardial infarction. Maraviroc dosage: 150 Mg, 2x/day. During the same period patient was treated with ABACAVIR (600 Mg, 1x/day) (View Abacavir Review and Abacavir Label ), ATAZANAVIR (Unk) (View Atazanavir Review and Atazanavir Label ), RITONAVIR (Unk) (View Ritonavir Review and Ritonavir Label ), TRAZODONE (Unk) (View Trazodone Review and Trazodone Label ), VITALUX (Unk) (View Vitalux Review and Vitalux Label ). Patient was hospitalized.

6723737-8 | Pancreatic Carcinoma
on May 13, 2010 Male patient from UNITED STATES , weighting 134.0 lb, was diagnosed with hiv infection (What is hiv infection?), hiv test positive (What is hiv test positive?), antifungal prophylaxis, insomnia, anxiety (What is anxiety?), chronic obstructive pulmonary disease, abdominal pain (What is abdominal pain?) and was treated with Maraviroc (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatic carcinoma. Maraviroc dosage: 300 Mg, 2x/day. During the same period patient was treated with TRUVADA (Unk) (View Truvada Review and Truvada Label ), ETRAVIRINE (Unk) (View Etravirine Review and Etravirine Label ), BACTRIM DS (Unk) (View Bactrim Ds Review and Bactrim Ds Label ), TRAZODONE (Unk) (View Trazodone Review and Trazodone Label ), XANAX (Unk) (View Xanax Review and Xanax Label ), MONTELUKAST SODIUM (Unk) (View Montelukast Sodium Review and Montelukast Sodium Label ), VICODIN ES (Unk) (View Vicodin Es Review and Vicodin Es Label ), ISENTRESS (Unk) (View Isentress Review and Isentress Label ).

6715452-1 | Cardiac Failure
Patient was taking Maraviroc (View Usage). Patient had the following side effects: cardiac failure on May 06, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 214.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Maraviroc dosage: 150 Mg, 2x/day.